Valuation: Ipca Laboratories Limited

Market Cap 487B 5.07B 4.46B 4.22B 3.83B 7.19B 7.23B 50.51B 19.51B 248B 19.04B 18.63B 798B P/E 2027 *
32.1x
P/E 2028 * 27.4x
Enterprise Value 476B 4.96B 4.36B 4.13B 3.74B 7.03B 7.07B 49.41B 19.08B 243B 18.63B 18.22B 781B EV / Sales 2027 *
4.33x
EV / Sales 2028 * 3.81x
Free-Float
54.94%
Yield 2027 *
0.3%
Yield 2028 * 0.32%
1 day+0.98%
1 week-2.73%
Current month-1.86%
1 month-1.86%
3 months+17.66%
6 months+21.04%
Current year+36.59%
1 week 1,902.3
Extreme 1902.3
2,020
1 month 1,902.3
Extreme 1902.3
2,038
Current year 1,391.8
Extreme 1391.8
2,038
1 year 1,251.6
Extreme 1251.6
2,038
3 years 917
Extreme 917
2,038
5 years 669.8
Extreme 669.8
2,038
10 years 200
Extreme 200
2,038
Manager TitleAgeSince
Chief Executive Officer 53 01/04/2023
Chief Executive Officer 70 01/04/2023
Chief Tech/Sci/R&D Officer 52 16/10/2023
Director TitleAgeSince
Chairman 79 05/07/2012
Director/Board Member 53 11/11/2008
Director/Board Member 70 01/08/1994
Date Insider Type Main position Quantity % Market Cap. Importance
19/12/24 Sell 4,000,000 1.5766%
Change 5-day change 1-year change 3-year change Capi.($)
+0.98%-2.73%+47.16%+107.14% 5.07B
+0.11%+1.71%+63.52%+117.61% 1,056B
+0.27%+0.92%+51.33%+73.35% 655B
+0.73%+0.68%+20.70%+74.90% 471B
-0.82%-3.08%+37.80%+40.91% 342B
+0.12%+4.47%+22.83%+29.60% 277B
+1.40%+0.06%+14.36%+14.21% 257B
+0.85%+6.35%+53.17%+54.39% 226B
+0.85%+1.10%+35.78%+101.82% 189B
+0.41%-2.26%-28.04%-60.72% 170B
Average +0.14%+0.43%+31.86%+55.32% 364.8B
Weighted average by Cap. -0.07%+1.04%+40.48%+69.94%

Financials

2027 *2028 *
Net sales 110B 1.15B 1.01B 953M 864M 1.62B 1.63B 11.41B 4.41B 56.11B 4.3B 4.21B 180B 123B 1.28B 1.12B 1.06B 964M 1.81B 1.82B 12.72B 4.91B 62.59B 4.8B 4.69B 201B
Net income 15.15B 158M 139M 131M 119M 224M 225M 1.57B 607M 7.73B 592M 580M 24.83B 17.8B 185M 163M 154M 140M 263M 264M 1.85B 713M 9.08B 696M 681M 29.18B
Net Debt -10.65B -111M -97.58M -92.27M -83.69M -157M -158M -1.1B -427M -5.43B -417M -408M -17.46B -19.96B -208M -183M -173M -157M -295M -296M -2.07B -800M -10.18B -781M -764M -32.72B
Logo Ipca Laboratories Limited
Ipca Laboratories Limited is an India-based integrated pharmaceutical company. The Company is engaged in manufacturing and marketing over 350 formulations and approximately 80 active pharmaceutical ingredients (APIs) covering various therapeutic segments. It offers APIs, such as Atenolol, Chloroquine Phosphate, Chlorthalidone, Furosemide, Hydroxychloroquine sulfate, Losartan, Metoprolol Succinate, Metoprolol Tartrate, Pyrantel Salts and Propranolol. The Company offers brands, such as Zerodol, Lariago, HCQS, Perinorm, Rapither AB, Tenoric, Lumerax, Etova, Fexova, Malirid, Allsuth, Alwiz, AZR 50mg, Bacilon, Cinkona, Clarbact, Glyree MV, Halotop, Luliz, Ozepam, Pacimol, Pari, Xtor-F, Zabpro, Zilast, Ramcor, Sove, Venpower and Folitrax. The Company’s products are sold in over 100 countries across the globe. The Company has 18 manufacturing units in India manufacturing APIs and formulations. Its subsidiaries include Ipca Pharmaceuticals, Inc. and Ipca Pharma Nigeria Ltd.
Employees
17,210
Date Price Change Volume
29/09/26 INR 1,938.10 +0.98% 246,042
28/09/26 INR 1,919.30 -2.61% 170,123
25/09/26 INR 1,970.80 -1.32% 263,825
24/09/26 INR 1,997.10 +1.76% 272,964
23/09/26 INR 1,962.60 -1.50% 159,445
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
1,919.30INR
Average target price
1,972.28INR
Spread / Average Target
+2.76%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IPCALAB Stock